Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
Go back to Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026| (NASDAQ: IPSC) | Delayed: 1.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.85 | 52 Week High | $ | |||
| Open | $1.85 | 52 Week Low | $ | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.85 | EPS | $ | |||
| Volume | 20 | |||||

